- Home
- DSGN vs CYH Comparison
DSGN vs CYH Comparison
Compare DSGN & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- CYH
- Stock Information
- Founded
- DSGN 2017
- CYH 1985
- Country
- DSGN United States
- CYH United States
- Employees
- DSGN N/A
- CYH N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- CYH Hospital/Nursing Management
- Sector
- DSGN Health Care
- CYH Health Care
- Exchange
- DSGN Nasdaq
- CYH Nasdaq
- Market Cap
- DSGN 348.2M
- CYH 373.7M
- IPO Year
- DSGN 2021
- CYH 1991
- Fundamental
- Price
- DSGN $4.01
- CYH $2.65
- Analyst Decision
- DSGN Buy
- CYH Hold
- Analyst Count
- DSGN 2
- CYH 7
- Target Price
- DSGN $8.00
- CYH $4.10
- AVG Volume (30 Days)
- DSGN 156.4K
- CYH 2.0M
- Earning Date
- DSGN 03-10-2025
- CYH 04-23-2025
- Dividend Yield
- DSGN N/A
- CYH N/A
- EPS Growth
- DSGN N/A
- CYH N/A
- EPS
- DSGN N/A
- CYH N/A
- Revenue
- DSGN N/A
- CYH $12,634,000,000.00
- Revenue This Year
- DSGN N/A
- CYH N/A
- Revenue Next Year
- DSGN N/A
- CYH $4.17
- P/E Ratio
- DSGN N/A
- CYH N/A
- Revenue Growth
- DSGN N/A
- CYH 1.15
- 52 Week Low
- DSGN $3.15
- CYH $2.53
- 52 Week High
- DSGN $7.77
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- DSGN 40.65
- CYH 40.94
- Support Level
- DSGN $4.06
- CYH $2.72
- Resistance Level
- DSGN $5.09
- CYH $2.85
- Average True Range (ATR)
- DSGN 0.38
- CYH 0.13
- MACD
- DSGN -0.08
- CYH 0.02
- Stochastic Oscillator
- DSGN 9.93
- CYH 45.71
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.